This Worthy Mid-Cap Fund Could Close Soon
Silver-rated Champlain Mid Cap is a suitable alternative to better-known Champlain Small Company, which is closed.
Silver-rated Champlain Mid Cap is a suitable alternative to better-known Champlain Small Company, which is closed.
Laura Lallos: We recently confirmed Morningstar Analyst Ratings of Silver for two funds from Burlington, Vermont, boutique Champlain Investment Partners.
Champlain Small Company (CIPSX) is the better known of the two, with a top-decile performance in the small-growth category over the past decade. It is currently closed to new investors, though.
However, Champlain Mid Cap (CIPMX) is a worthy alternative. It is also run by a long-tenured team led by firm co-founder Scott Brayman and emphasizes companies with low debt and quality earnings, with a strict valuation discipline. That's not a recipe for success in bull markets, but it has led to strong long-term risk-adjusted returns.
About 20% of Mid Cap's assets are in smaller-cap names also held in the Small Company fund, including molecular diagnostics firm Cepheid (CPHD), where volatility this year caused the managers to first take profits, then rebuild the position--illustrating their valuation discipline.
Shareholders benefit when management closes a fund to protect its strategy--and the Mid Cap fund is likely to close before the $5 billion point.
One beef with both funds: They have above-average expenses. But despite that hurdle, they've both outperformed their category peers in the past five years--with less risk.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals
and individual investors. These products and services are usually sold through
license agreements or subscriptions. Our investment management business generates
asset-based fees, which are calculated as a percentage of assets under management.
We also sell both admissions and sponsorship packages for our investment conferences
and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.